Company:  OPKO HEALTH, INC. (OPK)
Form Type:  4
Filing Date:  6/12/2019 
CIK:  0000944809 
Address:  4400 BISCAYNE BLVD. 
City, State, Zip:  MIAMI, Florida 33137 
Telephone:  305-575-4138 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.02  
Change: 
0.00 (0.00%)  
Trade Time: 
Jul 10  
Market Cap: 
$2.69B
Trade OPK now with 

© 2020  
Description of Business
We are a diversified healthcare company that seeks to establish industry-leading positions in large and rapidly growing medical markets. Our diagnostics business includes BioReference Laboratories, Inc. ("BioReference"), one of the nation's largest full service laboratories with a core genetic testing business and an almost 300-person sales and marketing team to drive growth and leverage new products, including the 4Kscore test. Our pharmaceutical business features Rayaldee, a, U.S. Food and Drug Administration ("FDA") approved treatment for secondary hyperparathyroidism ("SHPT") in adults with stage 3 or 4 chronic kidney disease ("CKD") and vitamin D insufficiency, a selective androgen receptor modulator which we are exploring for various potential indications, and a once weekly oxyntomodulin for type 2 diabetes and obesity which is a clinically advanced drug candidate among the new class of GLP-1 glucagon receptor dual agonists (phase 2b).
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES
  EXHIBIT 99